
Please try another search
ImmunoPrecise Antibodies Ltd. operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company. It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Name | Age | Since | Title |
---|---|---|---|
Jennifer Lynne Bath | - | 2018 | CEO, President & Non-Independent Director |
Dirk Witters | - | 2023 | Independent Chairman of the Board |
Kamil Isaev | - | 2025 | Independent Director |
Jeff Fried | - | 2025 | Member of Advisory Board |
Jonathan I. Lieber | 55 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review